JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265489

Human NARF (IOP2) knockout HeLa cell line

Be the first to review this product! 리뷰 제출

|

(0 출판물)

NARF KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 16 bp deletion in exon 3 and 1 bp deletion in exon 3 and 5 bp deletion in exon 3. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
3 이미지
Sanger Sequencing - Human NARF (IOP2) knockout HeLa cell line (AB265489)
  • Sanger seq

Unknown

Sanger Sequencing - Human NARF (IOP2) knockout HeLa cell line (AB265489)

Allele-1 : 16 bp deletion in exon 3.

Sanger Sequencing - Human NARF (IOP2) knockout HeLa cell line (AB265489)
  • Sanger seq

Unknown

Sanger Sequencing - Human NARF (IOP2) knockout HeLa cell line (AB265489)

Allele-3 : 1 bp deletion in exon 3.

Sanger Sequencing - Human NARF (IOP2) knockout HeLa cell line (AB265489)
  • Sanger seq

Unknown

Sanger Sequencing - Human NARF (IOP2) knockout HeLa cell line (AB265489)

Allele-2 : 5 bp deletion in exon 3.

주요 정보

세포 유형

HeLa

Species or organism

Human

조직

Cervix

제형

Liquid

form

Knockout 검증

Sanger Sequencing

Mutation 정보

Knockout achieved by using CRISPR/Cas9, 16 bp deletion in exon 3 and 1 bp deletion in exon 3 and 5 bp deletion in exon 3

질병

Adenocarcinoma

제품 세부 정보

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

제품 구성

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265489-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265489 Human NARF (IOP2) knockout HeLa cell line", "number":"AB265489-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265489-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265489-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265489-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265489 Human NARF (IOP2) knockout HeLa cell line", "number":"AB265489-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265489-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265489 Human NARF (IOP2) knockout HeLa cell line", "number":"AB265489-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265489-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265489 Human NARF (IOP2) knockout HeLa cell line", "number":"AB265489-CMP01", "productcode":"" } ] } } }

특성 및 보관 정보

유전자명
NARF
유전자 편집 종류
Knockout
유전자 편집 방식
CRISPR technology
Knockout 검증
Sanger Sequencing
배송 시 보관 조건
Dry Ice
적절한 단기 보관 조건
-196°C
적절한 장기 보관 조건
-196°C

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

IOP2 also known by alternate names programmable cell death protein 6-interacting protein or PDCD6IP plays a role in cellular mechanisms involving vesicle trafficking and endocytosis. This protein approximately weighs 80 kDa and is widely expressed in various tissues including brain liver and heart. IOP2 exhibits interactions with other proteins within the cell enabling the formation of multitumor suppressor complexes that regulate cell survival and division.
Biological function summary

IOP2 functions in intracellular signaling and membrane dynamics. It participates as a component of the ESCRT (endosomal sorting complexes required for transport) machinery. In this context IOP2 facilitates the sorting of ubiquitinated transmembrane proteins into the internal vesicles of multivesicular bodies. Its activity in this complex highlights the regulation of down-regulating surface receptors and contributing to the cellular homeostasis.

Pathways

IOP2 interacts with mechanisms controlling cellular growth and apoptosis. One of the significant pathways includes the mitogen-activated protein kinase (MAPK) signaling which influences cell proliferation. Within this pathway IOP2 relates to proteins such as ERK1/2 playing a role in the signal transduction processes. Additionally the protein contributes to the regulation of PI3K/AKT pathway impacting cell survival through its interactions within the signaling network.

IOP2 exhibits connection to cancer and neurodegenerative disorders. In oncological contexts altered IOP2 expression links with esophageal squamous cell carcinoma suggesting a role in tumor progression. Additionally in neurodegenerative conditions IOP2 interaction with Alzheimer's disease-related proteins like amyloid precursor protein (APP) reflects its involvement in pathological processes. Changes in IOP2 function or expression may therefore serve as potential biomarkers or targets for therapeutic intervention in these diseases.

품질 관리

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

초기 취급 지침

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability. <p>1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.<br>2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.<br>3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.<br>4. Incubate the culture at 37°C incubator with 5% CO<sub>2</sub>. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.<br>5. Once confluent passage into an appropriate flask at a density of 2x10<sup>4</sup> cells/cm<sup>2</sup>. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.</p>

Subculture 가이드라인
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
배양 배지

DMEM (High Glucose) + 10% FBS

동결보존 배지

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

제품 프로토콜

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com